Menu
Recruiting NCT07345949

Panniculitis in Dermatomyositis

Observational Panniculitis Dermatomyositis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Panniculitis, Dermatomyositis. Basic parameters: from 1 year · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Adipose tissue involvement is rare in dermatomyositis. The occurrence of partial or diffuse lipodystrophy is a rare but well-characterized manifestation, particularly in juvenile forms of dermatomyositis. Panniculitis, on the other hand, is exceptional and rarely described in the literature, mostly in the form of clinical cases. Panniculitis in dermatomyositis is exceptional. There are no validated diagnostic criteria or treatment recommendations. Treatment is based, by analogy, on the therapeutic strategy for lupus panniculitis and involves synthetic antimalarials combined with steroids and/or immunosuppressants. The aim of this study is to describe panniculitis in dermatomyositis in order to determine whether there are clinical or histological characteristics that distinguish it from other causes of panniculitis, particularly panniculitis associated with lupus erythematosus.

Primary outcome measures

  • Determine the clinical and histological characteristics of panniculitis in dermatomyositis [Time frame: Up to 30 months]

Eligibility criteria

Inclusion criteria

  • Subject aged 1 year and older
  • With a confirmed diagnosis of dermatomyositis
  • With a confirmed diagnosis of panniculitis

Exclusion criteria

  • Panniculitis for which another cause has been established, particularly infectious and metabolic panniculitis

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

France · 1 center
  • Service de dermatologie - CHU de Strasbourg - France — Strasbourg

Identifiers

NCT: NCT07345949 · 9944

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗